Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B.
Abstract
Early curative applications of the aminoglycoside WR279396 on an experimental Leishmania major-loaded cutaneous site do not impair the acquisition of immunity.
Abstract
Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis.
Abstract
Individual variability of the cutaneous larva migrans (CLM) incubation period.
Abstract
Unusual location of an inoculation lesion in a traveler with African tick-bite fever returning from South Africa.
Abstract
Pathological rupture of the spleen in malaria: analysis of 55 cases (1958-2008).
Abstract
WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study.
Abstract
Artesunate for severe acute Plasmodium falciparum infection in a patient with myasthenia gravis.
Abstract
Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria.
Abstract
Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins.
Abstract